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criterion). The double-arc plans had couch included in the dose 
calculation. Similarly single-arc plans (98.67%), simple pelvic plans 
(99.9%), and single target volume plans (98.8%) showed more % of 
pixels passing the criterion than the complex double-arc plans. Only 
the plans which didn’t include the couch in the dose calculation 
showed poorer results. The p-values in student’s t-test showed 
significant variations in the gamma values in comparisons.  
Conclusions: Optimization of patient specific QA should take into 
account of all the affecting factors like type of delivery, number of 
arcs, complexity (treatment site), number of target volumes, and 
inclusion/exclusionof couch in the plans.  
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Purpose/Objective: Traditional patient specific quality assurance 
(QA) is based on gamma values that may not detect small but 
clinically significant variations between the plan and delivered dose. 
For applications which operate near the limits of machine capabilities 
and tolerance doses, such as hypo fractionated volumetric modulated 
arc therapy (VMAT), dose volume histogram (DVH) based analysis is 
preferred. The purpose of this work is to present the principles of a 
DVH based QA technique using radiochromic film in a cylindrical 
phantom. 
Materials and Methods 
1. A VMAT plan was created for a lung patient with a commercial 
treatment planning system (Varian Eclipse). Commonly such 
plans consist of a clock wise and a counter clockwise 360 degree 
arc. Using the proposed technique requires that each field be 
split into two 180 degree arcs so that we can acquire the 
entrance and exit doses simultaneously on gafchromic film (ISP 
EBT3) surrounding a cylindrical phantom at Dmax.  
2. A Verification Plan (VP) is created in Eclipse for both the patient 
and the phantom. Note that VP has the ability to modify several 
plan parameters such as Monitor Units (MU), Micro Leaf 
Collimator positions, and arc angles corresponding to the plan 
control points. This capability has not been presented or 
exploited in any previous work.  
3. The MUs for one control point in the patient VP were modified 
to represent possible delivery error. The plan was delivered to 
the phantom on a Varian TrueBeam Linac and the film processed 
according to the manufacturers recommendations using only the 
red color component.  
4. Comparison of the planned phantom dose (PPD) and the actual 
measured phantom dose (MPD) in is performed in MATLAB with 
the imaging toolbox. Algorithms compute the gantry angle, field 
size, and the ratio of the measured to plan dose for any 
modified control points.  
5. The measured control point modifications were incorporated 
back into the patient VP and an updated modified patient dose 
distribution computed. DVH tools in Eclipse are used for 
comparison of the original patient plan and modified patient 
plan. Note that all calculations are performed within the same 
treatment planning system thereby avoiding differences due to 
calculation algorithms.  
Results: Experimental studies show that changes in a single control 
point such as shown in Figure 1 can be detected and they can lead to 
significant clinical changes, including maximum dose to a critical 
organ. 
The detail in Figure 1 is sufficient to resolve 2.5 mm MLC leaves. 
The observed intensity pattern differs slightly from the expected dose 
of a single control point. Further investigation is required to see if this 
is due to leaf motion during rotation between control points. 
 
Figure 1. 
Conclusions: We have described a QA technique for DVH comparison 
of a computed patient plan with the actual delivered plan using a 
commercial treatment planning system and measurements with 
radiochromic film in a cylindrical phantom. 
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Purpose/Objective: We investigated a commercial system, consisting 
of the ArcCHECK (AC) dosimeter and 3DVH (Version 2.2, Sun Nuclear 
Corp). This combination allows reconstructing 3D patient dose based 
on measurements. The objective of this work is to study the behaviour 
of the Planned Dose Perturbation (ACPDP) algorithm and to investigate 
its accuracy under different basic situations. 
Materials and Methods: In our scenario the phantom is considered as 
the patient, allowing independent measurements. To investigate the 
performance of ACPDP we introduced three kinds of 'errors' into 
simple reference plans. It was then examined whether ACPDP could 
reproduce the dose of the modified plan, using the (non-modified) 
reference plan as a-priori knowledge and the AC measurements of the 
modified plan. The errors introduced into a homogenous static field 
were (a) an over-dosage (1 to 5%) in areas of different size, and (b) a 
variation of the MLC field width (±2 to ±8 mm). The error (c) was 
introduced into a dynamic arc field (90° to 270°) simulating a 
deviation of MLC position (±2 to ±10 mm) of 1/3 of the leaves. All 
measurements were performed on a Varian CLINAC 2100CD, dose 
calculation in Eclipse (TPS: AAA 10.0.28). Ion chamber (IC) and EBT3 
film were used to establish the TPS as a very accurate reference. 
Results: TPS dose calculation agreed very well with IC (-0.4 to 0.6%) 
and selected AC diodes (-0.8 to 1.3%). Relative film measurements 
confirmed the very accurate TPS calculation of gradients at field 
edges. Error (a) could clearly be found in the dose reconstructed by 
3DVH (agreement within ±0.5%) as long as the 'High Sensitivity' (HS) 
mode of the ACPDP algorithm was used and the area was larger then 
1x1 cm². The error was ignored for smaller areas and with ACPDP in 
'Normal Sensitivity' (NS) mode. The deviation (b) was clearly 
recognized by the AC diodes. Still, almost no influence of the 
measurements could be seen at the field edge in the ACPDP-
calculated dose (HS) based on those measurements. The error was 
either ignored completely or an unrealistic interpolation between 
expected and measured dose was performed (Fig. 1a). Error (c) 
extends the results of (b). Again, although the error was measured, 
ACPDP-calculated dose (HS) shows increasing deviations from the 
expected dose with increasing error. The effect is more pronounced in 
the periphery where the differences exceed 3% for a 2 mm MLC 
displacement and go up to more than 15% for 10 mm. The agreement 
in the phantom centre was better, ranging from 0.8 to 2.9% (Fig. 1b). 
 
